Summary

U.S. Dermal Fillers Market – Scope of Report
TMR’s report on the U.S. dermal fillersg market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the U.S. dermal fillersg market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the U.S. dermal fillersg market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the dermal fillersg market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the U.S. dermal fillersg market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the U.S. dermal fillersg market. These serve as valuable tools for existing market players as well as for entities interested in participating in the U.S. dermal fillersg market.

The report delves into the competitive landscape of the U.S. dermal fillersg market. Key players operating in the U.S. dermal fillersg market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the U.S. dermal fillersg market profiled in this report.

Key Questions Answered in U.S. dermal fillersg Market Report
• What is the sales/revenue generated by dermal fillersg across all regions during the forecast period?
• What are the opportunities in the U.S. dermal fillersg market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue U.S.ly in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the U.S. market?

U.S. Dermal Fillers Market – Research Objectives and Research Approach
The comprehensive report on the U.S. dermal fillersg market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the U.S. dermal fillersg market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the U.S. dermal fillersg market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: U.S. Dermal Fillers Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. U.S. Dermal Fillers Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario in the U.S.
5.2. Pricing Analysis: Treatment Cost and Product Cost for End-users
5.3. Key Product/Brands Analysis
5.4. Key Industry Events (Product Launch, Mergers & Acquisitions, and Approval)
6. U.S. Dermal Fillers Market Analysis and Forecasts, By Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product, 2020-2034
6.3.1. Biodegradable
6.3.2. Non-biodegradable
6.4. Market Attractiveness By Product
7. U.S. Dermal Fillers Market Analysis and Forecasts, By Material
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Material, 2020-2034
7.3.1. Calcium Hydroxylapatite
7.3.2. Hyaluronic Acid
7.3.3. Poly-L-lactic Acid
7.3.4. PMMA
7.3.5. Others
7.4. Market Attractiveness By Material
8. U.S. Dermal Fillers Market Analysis and Forecasts, By Gender
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Gender, 2020-2034
8.3.1. Female
8.3.2. Male
8.4. Market Attractiveness By Gender
9. U.S. Dermal Fillers Market Analysis and Forecasts, By Application
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Application, 2020-2034
9.3.1. Facial Line Correction Treatment
9.3.2. Facial Volume Enhancement
9.3.3. Scar Treatment
9.3.4. Others
9.4. Market Attractiveness By Application
10. U.S. Dermal Fillers Market Analysis and Forecasts, By End-user
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast By End-user, 2020-2034
10.3.1. Hospitals
10.3.2. Dermatology Clinics
10.3.3. MedSpas
10.3.4. Others
10.4. Market Attractiveness By End-user
11. U.S. Dermal Fillers Market Analysis and Forecasts, By Region
11.1. Key Findings
11.2. Market Value Forecast By Region
11.2.1. Northeast Region
11.2.2. Midwest Region
11.2.3. South Region
11.2.4. West Region
11.3. Market Attractiveness By Region
12. Northeast Region Dermal Fillers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product, 2020-2034
12.2.1. Biodegradable
12.2.2. Non-biodegradable
12.3. Market Value Forecast By Material, 2020-2034
12.3.1. Calcium Hydroxylapatite
12.3.2. Hyaluronic Acid
12.3.3. Poly-L-lactic Acid
12.3.4. PMMA
12.3.5. Others
12.4. Market Value Forecast By Gender, 2020-2034
12.4.1. Female
12.4.2. Male
12.5. Market Value Forecast By Application, 2020-2034
12.5.1. Facial Line Correction Treatment
12.5.2. Facial Volume Enhancement
12.5.3. Scar Treatment
12.5.4. Others
12.6. Market Value Forecast By End-user, 2020-2034
12.6.1. Hospitals
12.6.2. Dermatology Clinics
12.6.3. MedSpas
12.6.4. Others
12.7. Market Value Forecast By State/Sub-region, 2020-2034
12.7.1. New York
12.7.2. Pennsylvania
12.7.3. Massachusetts
12.7.4. New Jersey
12.7.5. Rest of Northeast Region
12.8. Market Attractiveness Analysis
12.8.1. By Product
12.8.2. By Material
12.8.3. By Gender
12.8.4. By Application
12.8.5. By End-user
12.8.6. By State/Sub-region
13. Midwest Region Dermal Fillers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product, 2020-2034
13.2.1. Biodegradable
13.2.2. Non-biodegradable
13.3. Market Value Forecast By Material, 2020-2034
13.3.1. Calcium Hydroxylapatite
13.3.2. Hyaluronic Acid
13.3.3. Poly-L-lactic Acid
13.3.4. PMMA
13.3.5. Others
13.4. Market Value Forecast By Gender, 2020-2034
13.4.1. Female
13.4.2. Male
13.5. Market Value Forecast By Application, 2020-2034
13.5.1. Facial Line Correction Treatment
13.5.2. Facial Volume Enhancement
13.5.3. Scar Treatment
13.5.4. Others
13.6. Market Value Forecast By End-user, 2020-2034
13.6.1. Hospitals
13.6.2. Dermatology Clinics
13.6.3. MedSpas
13.6.4. Others
13.7. Market Value Forecast By State/Sub-region, 2020-2034
13.7.1. Ohio
13.7.2. Indiana
13.7.3. Illinois
13.7.4. Michigan
13.7.5. Rest of Midwest Region
13.8. Market Attractiveness Analysis
13.8.1. By Product
13.8.2. By Material
13.8.3. By Gender
13.8.4. By Application
13.8.5. By End-user
13.8.6. By State/Sub-region
14. South Region Dermal Fillers Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product, 2020-2034
14.2.1. Biodegradable
14.2.2. Non-biodegradable
14.3. Market Value Forecast By Material, 2020-2034
14.3.1. Calcium Hydroxylapatite
14.3.2. Hyaluronic Acid
14.3.3. Poly-L-lactic Acid
14.3.4. PMMA
14.3.5. Others
14.4. Market Value Forecast By Gender, 2020-2034
14.4.1. Female
14.4.2. Male
14.5. Market Value Forecast By Application, 2020-2034
14.5.1. Facial Line Correction Treatment
14.5.2. Facial Volume Enhancement
14.5.3. Scar Treatment
14.5.4. Others
14.6. Market Value Forecast By End-user, 2020-2034
14.6.1. Hospitals
14.6.2. Dermatology Clinics
14.6.3. MedSpas
14.6.4. Others
14.7. Market Value Forecast By State/Sub-region, 2020-2034
14.7.1. Texas
14.7.2. Florida
14.7.3. Georgia
14.7.4. North Carolina
14.7.5. Rest of South Region
14.8. Market Attractiveness Analysis
14.8.1. By Product
14.8.2. By Material
14.8.3. By Gender
14.8.4. By Application
14.8.5. By End-user
14.8.6. By State/Sub-region
15. West Region Dermal Fillers Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product, 2020-2034
15.2.1. Biodegradable
15.2.2. Non-biodegradable
15.3. Market Value Forecast By Material, 2020-2034
15.3.1. Calcium Hydroxylapatite
15.3.2. Hyaluronic Acid
15.3.3. Poly-L-lactic Acid
15.3.4. PMMA
15.3.5. Others
15.4. Market Value Forecast By Gender, 2020-2034
15.4.1. Female
15.4.2. Male
15.5. Market Value Forecast By Application, 2020-2034
15.5.1. Facial Line Correction Treatment
15.5.2. Facial Volume Enhancement
15.5.3. Scar Treatment
15.5.4. Others
15.6. Market Value Forecast By End-user, 2020-2034
15.6.1. Hospitals
15.6.2. Dermatology Clinics
15.6.3. MedSpas
15.6.4. Others
15.7. Market Value Forecast By State/Sub-region, 2020-2034
15.7.1. California
15.7.2. Arizona
15.7.3. Colorado
15.7.4. Washington
15.7.5. Rest of West Region
15.8. Market Attractiveness Analysis
15.8.1. By Product
15.8.2. By Material
15.8.3. By Gender
15.8.4. By Application
15.8.5. By End-user
15.8.6. By State/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles
16.2.1. Galderma S.A.
16.2.1.1. Company Overview
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Business Strategies
16.2.1.5. Recent Developments
16.2.2. Revance Therapeutics, Inc.
16.2.2.1. Company Overview
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Business Strategies
16.2.2.5. Recent Developments
16.2.3. AbbVie, Inc. (Allergan Aesthetics)
16.2.3.1. Company Overview
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Business Strategies
16.2.3.5. Recent Developments
16.2.4. Merz Pharma GmbH & Co. KGa (Merz North America, Inc.)
16.2.4.1. Company Overview
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Business Strategies
16.2.4.5. Recent Developments
16.2.5. Suneva Medical, Inc.
16.2.5.1. Company Overview
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Business Strategies
16.2.5.5. Recent Developments
16.2.6. Prollenium Medical Technologies Inc.
16.2.6.1. Company Overview
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Business Strategies
16.2.6.5. Recent Developments
16.2.7. Teoxane SA
16.2.7.1. Company Overview
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Business Strategies
16.2.7.5. Recent Developments